Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale President and CEO sold 28,502 shares at an average $6.23 ($177,509)
  8. 4 Grant or award EVP & Chief Medical Officer acquired 65,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Chief Scientific Officer acquired 60,000 shares (grant or award)
  11. 4 Open-market sale EVP, Chief Dev. Officer sold 1,663 shares at $10.24 ($17,025)
  12. 4 Open-market sale EVP, CFO & Treasurer sold 2,398 shares at $10.24 ($24,550)
  13. 4 Open-market sale Chief Scientific Officer sold 12,452 shares at $10.24 ($127,477)
  14. 4 Open-market sale Director sold 12,452 shares at $10.24 ($127,477)
  15. 4 Grant or award SVP, Chief Business Officer acquired 47,250 shares (grant or award)
  16. 4 Grant or award Chief Commercial Officer acquired 84,000 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 288,750 shares (grant or award)
  18. 4 Grant or award SVP, General Counsel&Secretary acquired 63,000 shares (grant or award)
  19. 4 Open-market sale EVP, Chief Medical Officer sold 1,306 shares at $12.12 ($15,833)
  20. 4 Open-market sale EVP, Chief Dev. Officer sold 2,929 shares at $12.12 ($35,509)

Page 10 of 31 · 601 filings